معرفی
Professor Deborah Ashby serves as Dean of the Faculty of Medicine at Imperial College London and holds the Chair in Medical Statistics and Clinical Trials. She previously directed the School of Public Health and co-founded the Imperial Clinical Trials Unit. Her research focuses on clinical trials methodology, risk-benefit analysis for medications, and Bayesian statistical approaches. She has held prestigious roles including Royal Statistical Society President (2019-2020) and was elected to the Royal Society in 2025.
Notable accolades include an OBE (2009), NIHR Senior Investigator designation (2010), and Academy of Medical Sciences membership (2012). Her work has significantly impacted national pandemic response through the REACT studies, analyzing SARS-CoV-2 prevalence and antibody dynamics across millions of participants.
- Key contributions: Development of SPIRIT-DEFINE and CONSORT-DEFINE guidelines for dose-finding trials
- Leadership roles: Academic governance, cross-disciplinary collaboration in public health
- Current initiatives: Advancing medical statistics education and translational research
Her research portfolio includes over 200 peer-reviewed articles addressing pandemic dynamics, clinical trial design, and healthcare evaluation. Ongoing work focuses on optimizing diagnostic testing strategies and improving benefit-risk frameworks in therapeutic development.
